Working... Menu
Trial record 1 of 1 for:    khb-1802
Previous Study | Return to List | Next Study

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular Age-related Macular Degeneration (PANDA-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03630952
Recruitment Status : Recruiting
First Posted : August 15, 2018
Last Update Posted : March 5, 2019
Information provided by (Responsible Party):
Chengdu Kanghong Biotech Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 20, 2020
  Estimated Study Completion Date : March 29, 2022